# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001213900-25-056909
Filing Date
2025-06-24
Accepted
2025-06-24 07:45:13
Documents
50
Period of Report
2025-06-24
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | CURRENT REPORT | ea0246672-8k_nektar.htm iXBRL | 8-K | 68256
2 | PRESS RELEASE ISSUED BY NEKTAR THERAPEUTICS ON JUNE 24, 2025, FURNISHED HEREWITH | ea024667201ex99-1_nektar.htm | EX-99.1 | 52221
3 | NEKTAR THERAPEUTICS CORPORATE PRESENTATION, FURNISHED HEREWITH | ea024667201ex99-2_nektar.htm | EX-99.2 | 68081
4 | GRAPHIC | ex99-1_001.jpg | GRAPHIC | 2044
5 | GRAPHIC | ex99-2_001.jpg | GRAPHIC | 207827
6 | GRAPHIC | ex99-2_002.jpg | GRAPHIC | 590252
7 | GRAPHIC | ex99-2_003.jpg | GRAPHIC | 292188
8 | GRAPHIC | ex99-2_004.jpg | GRAPHIC | 276531
9 | GRAPHIC | ex99-2_005.jpg | GRAPHIC | 368939
10 | GRAPHIC | ex99-2_006.jpg | GRAPHIC | 217459
11 | GRAPHIC | ex99-2_007.jpg | GRAPHIC | 257304
12 | GRAPHIC | ex99-2_008.jpg | GRAPHIC | 190803
13 | GRAPHIC | ex99-2_009.jpg | GRAPHIC | 212795
14 | GRAPHIC | ex99-2_010.jpg | GRAPHIC | 198287
15 | GRAPHIC | ex99-2_011.jpg | GRAPHIC | 231330
16 | GRAPHIC | ex99-2_012.jpg | GRAPHIC | 235272
17 | GRAPHIC | ex99-2_013.jpg | GRAPHIC | 241155
18 | GRAPHIC | ex99-2_014.jpg | GRAPHIC | 273735
19 | GRAPHIC | ex99-2_015.jpg | GRAPHIC | 228617
20 | GRAPHIC | ex99-2_016.jpg | GRAPHIC | 351029
21 | GRAPHIC | ex99-2_017.jpg | GRAPHIC | 216994
22 | GRAPHIC | ex99-2_018.jpg | GRAPHIC | 245173
23 | GRAPHIC | ex99-2_019.jpg | GRAPHIC | 242373
24 | GRAPHIC | ex99-2_020.jpg | GRAPHIC | 384686
25 | GRAPHIC | ex99-2_021.jpg | GRAPHIC | 336638
26 | GRAPHIC | ex99-2_022.jpg | GRAPHIC | 173671
27 | GRAPHIC | ex99-2_023.jpg | GRAPHIC | 229486
28 | GRAPHIC | ex99-2_024.jpg | GRAPHIC | 190182
29 | GRAPHIC | ex99-2_025.jpg | GRAPHIC | 251469
30 | GRAPHIC | ex99-2_026.jpg | GRAPHIC | 264532
31 | GRAPHIC | ex99-2_027.jpg | GRAPHIC | 257364
32 | GRAPHIC | ex99-2_028.jpg | GRAPHIC | 182305
33 | GRAPHIC | ex99-2_029.jpg | GRAPHIC | 305087
34 | GRAPHIC | ex99-2_030.jpg | GRAPHIC | 386040
35 | GRAPHIC | ex99-2_031.jpg | GRAPHIC | 438780
36 | GRAPHIC | ex99-2_032.jpg | GRAPHIC | 329707
37 | GRAPHIC | ex99-2_033.jpg | GRAPHIC | 327800
38 | GRAPHIC | ex99-2_034.jpg | GRAPHIC | 325269
39 | GRAPHIC | ex99-2_035.jpg | GRAPHIC | 306225
| Complete submission text file | 0001213900-25-056909.txt |  | 13847121

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
40 | XBRL SCHEMA FILE | nktr-20250624.xsd | EX-101.SCH | 3008
41 | XBRL LABEL FILE | nktr-20250624_lab.xml | EX-101.LAB | 34239
42 | XBRL PRESENTATION FILE | nktr-20250624_pre.xml | EX-101.PRE | 22354
52 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0246672-8k_nektar_htm.xml | XML | 3565

Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 251066696
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)